Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)
Recruiting · NCT06546267 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This is a retrospective monoinstitutional study which analyses the results of advanced radiotherapy (IGRT, IMRT, SBRT, and PET-guided) performed for radical, adjuvant, or salvage purposes in patients with low, intermediate, high, and very high-risk prostate cancer, or with biochemical, lymph node, or oligometastatic recurrence treated between 2004 and 2024. Approved by Ethics Committee of IRCCS San Raffaele Hospital Approval Number: 187/INT/2021, 03/02/2022 Amendment approved by Ethics Committee 1, Lombardy Region Approval number CET Em. 194-2024, 22/05/2024
Who can take part
Age range
18 Years to 95 Years
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Prostate cancer patients, \> 18 years old, treated with IGRT, IMRT, SBRT
Exclusion criteria
- other tumors
- \> 95 years old
Where it is running
1 location listed.
- IRCCS San Raffaele Scientific Institute - Milan, Italy